Alcon
Alcon is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It is headquartered in Geneva, Switzerland and has a major presence in Fort Worth, Texas, United States, where it employs about 4,500 people.
Native name | Alcon AG |
|---|---|
| Company type | Public (Aktiengesellschaft) |
| Industry | Ophthalmology |
| Founded | 1945 in Fort Worth, Texas, United States |
| Headquarters | Geneva , Switzerland |
Key people | David Endicott (CEO) |
| Products | |
| Revenue | US$8.3 billion (2021) |
| US$580 million (2021) | |
| US$376 million (2021) | |
| Total assets | US$28.0 billion (2021) |
| Total equity | US$19.2 billion (2021) |
Number of employees | 24,389 (end 2021) |
| Website | www |
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.